NCT04257097

Brief Summary

The objective of this study is to compare two surgical techniques for the treatment of the maxillary and mandibular bone atrophies.. Therefore, the main purpose is to compare the (i) the percentage of post-operative complications (ii) the three-dimensional bone gain with customized titanium meshes (test group - the medical device is digitally designed and made with customized laser sintering modality, customized to the defect of each patient) and with titanium-reinforced PTFE mesh (control group - the medical device is cut, shaped, and manually modelled to the patient's defect by the operator himself.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 6, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 5, 2020

Completed
25 days until next milestone

Study Start

First participant enrolled

March 1, 2020

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2022

Completed
2.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

March 14, 2025

Status Verified

March 1, 2025

Enrollment Period

2.7 years

First QC Date

December 6, 2019

Last Update Submit

March 12, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • The rate of healing complications after reconstructive surgery

    Healing complications are evaluated based on the chronological order in which they occur: * immediate exposure occurs within the 1st month * early exposure occurs between the 1st and the 3rd month * late exposure occurs between after the 3rd month Evaluation of low-grade and high-grade infection of medical devices used for bone regeneration. The former complications are classified as: * Class A, including flap damage (soft tissue perforation or laceration) * Class B, including neurological damage (paresthesia or disesthesia) * Class C,including vascular damage (hemorrhage). The latter complications are divided into four classes, according to the presence and extent of exposure, as well as the presence of a purulent exudate: * Class I, membrane exposure \<3 mm, no purulent exudate * Class II membrane exposure \>=3mm, no purulent exudate * Class III: membrane exposure, with purulent exudate

    6 months

Secondary Outcomes (16)

  • Level of anxiety of the patient measured with a Visual Analogue Scale (VAS)

    Immediately before/after the surgery

  • Pain level of the patient measured on a Visual Analogue Scale (VAS)

    Post operative from immediately after surgery to the 14th day after the surgery.

  • Total Number of painkillers taken post-operative

    Post operative from immediately after surgery to the 14th day after the surgery.

  • Dosage of painkillers

    Post operative from immediately after surgery to the 14th day after the surgery.

  • Limitation in daily functions measured on a Visual Analogue Scale (VAS)

    Post operative from immediately after surgery to the 14th day after the surgery.

  • +11 more secondary outcomes

Study Arms (2)

Group A - control group

ACTIVE COMPARATOR

25 patients will undergo bone regeneration with a titanium reinforced PTFE Mesh (RPM - Osteogenics Lubbock Texas USA), manually shaped and modeled by the operator during surgery (traditional technique), covered with collagen membranes of medium-rapid resorption (Vitala - Osteogenics Lubbock Texas USA)

Device: RPM - Osteogenics Lubbock Texas USA

Group B - Test group

EXPERIMENTAL

25 patients undergo bone regeneration with a custom-made titanium mesh (Yxoss CBR - Reoss Filderstadt Germany), digitally designed by an operator before the surgery (digital technique), covered by collagen membranes with medium-rapid resorption (Bio-Gide - Geistlich Baden Baden Germany)

Device: Yxoss CBR - Reoss Filderstadt Germany

Interventions

25 patients will undergo bone regeneration with a reinforced PTFE mesh, manually shaped and modelled by the operator during surgery (traditional technique), covered with collagen membranes of medium-rapid resorption

Also known as: Vitala - Osteogenics Lubbock Texas USA
Group A - control group

25 patients undergo bone regeneration with a custom-made titanium mesh, digitally designed by an operator before the surgery (digital technique), covered by collagen membranes with medium-rapid resorption

Also known as: Bio-Gide - Geistlich Baden Baden Germany
Group B - Test group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients, over the age of 18, in good general health.
  • Patients with partial edentulism of the maxilla or mandible, with a 2mm minimum to a 12mm maximum vertical bone defect, which requires a three-dimensional bone regeneration intervention in order to have a fixed implant supported rehabilitation.
  • Obtaining informed consent for experimental treatment and processing the personal data.

You may not qualify if:

  • Poor oral hygiene,
  • Untreated periodontal disease
  • Smoking habit\> 10 cigarettes / day;
  • Abuse of alcohol or drugs
  • Pregnancy
  • Patients with odontostomatological infections and / or systemic infections in progress;
  • Patient with uncontrolled diabetes mellitus or other metabolic diseases;
  • Patients with severe changes in liver and kidney function.
  • Patients with confirmed uncontrolled autoimmune disorders.
  • Patients subjected radiation therapy in the head or neck region in the last 5 years.
  • Patients undergoing immunosuppressive and / or immunocompromised therapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School of Dentistry - University of Bologna

Bologna, Italy, 40126, Italy

Location

MeSH Terms

Conditions

Soft Tissue InfectionsSurgical Wound DehiscenceBone Diseases, Metabolic

Condition Hierarchy (Ancestors)

InfectionsPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Giuseppe Corinaldesi, MD,DDS,MS

    School of dentistry - University of Bologna

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The surgeon is masked until the envelope is opened at the time of the surgery.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
NETWORK
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 6, 2019

First Posted

February 5, 2020

Study Start

March 1, 2020

Primary Completion

November 1, 2022

Study Completion

March 1, 2025

Last Updated

March 14, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will share

Original articles in international journals

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
From January 2021
Access Criteria
Access credentials to journal resources

Locations